Concepedia

Alexa Michel

AM

Statistics

Publications

6

Citations

929

H-Index

6

Active since

2005

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Broad Institute

Dana-Farber Cancer Institute

Alexa Michel is an author at Massachusetts General Hospital specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2005–2024

6

Publications

6

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

Noritaka Tanaka, Chendi Li, Meagan B. Ryan et al. · Cancer Discovery · 2021 · 517 citations · Full text

, , +14

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

Jun Tian, Jonathan Chen, Sherry Chao et al. · Nature Medicine · 2023 · 187 citations · Full text

, , +17

Cell‐free human papillomavirus DNA kinetics after surgery for human papillomavirus–associated oropharyngeal cancer

Connor J. O'Boyle, Giulia Siravegna, Shohreh Varmeh et al. · Cancer · 2022 · 83 citations · Full text

, , +12

Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma

Qibiao Wu, Haley Ellis, Giulia Siravegna et al. · Clinical Cancer Research · 2023 · 78 citations · Full text

, , +17

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

Ryan B. Corcoran, T. Khanh, Jeong Eun Kim et al. · Clinical Cancer Research · 2024 · 35 citations · Full text

, , +17

1–5 of 6